Loading clinical trials...
Loading clinical trials...
This study is open to people aged 18 to 65 who have post-traumatic stress disorder. The purpose of this study is to find out whether a medicine called BI 1358894 improves symptoms in people with post-...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Boehringer Ingelheim
NCT06002633 · Post-Traumatic Stress Disorder, Alcohol Drinking
NCT07447089 · Thyroid Neoplasms, Neoplasm, and more
NCT03233646 · Alzheimer's Disease, Mild Cognitive Impairment, and more
NCT06516874 · Post Traumatic Stress Disorder, Complex Post-Traumatic Stress Disorder
NCT06854328 · Post-Traumatic Stress Disorder in Adolescence
Woodland International Research Group, Inc.
Little Rock, Arkansas
Behavioral Research Specialists, LLC
Glendale, California
ASCLEPES Research Centers, P.C. dba Alliance Research
Long Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions